Kiniksa Pharmaceuticals to Report Third Quarter 2025 Financial Results on October 28, 2025

Rhea-AI Summary

Kiniksa Pharmaceuticals (Nasdaq: KNSA) will report third quarter 2025 results and recent portfolio execution on Tuesday, October 28, 2025 at 8:30 a.m. ET. The company will host a conference call and live webcast accessible via the Investors & Media section of www.kiniksa.com.

Participants can register to join by telephone and will receive a confirmation email with dial-in details, a unique passcode, and registrant ID. A replay will be available on Kiniksa’s website approximately 48 hours after the event.

News Market Reaction – KNSA

+0.41%

+0.41% Session close to close

In the Oct 24 session, KNSA gained 0.41%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LONDON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 28, 2025 at 8:30 a.m. Eastern Time to report its third quarter 2025 financial results and recent portfolio execution.

A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register here. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.

About Kiniksa
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. For more information, please visit www.kiniksa.com.

Every Second Counts! ^®

Kiniksa Investor & Media Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com

FAQ

When will Kiniksa (KNSA) report third quarter 2025 financial results?

Kiniksa will report results on October 28, 2025 with a conference call at 8:30 a.m. ET.

How can investors access the Kiniksa (KNSA) Q3 2025 webcast?

The live webcast will be available via the Investors & Media section of www.kiniksa.com.

How do I join Kiniksa's (KNSA) conference call by phone for October 28, 2025?

Register through the provided registration link; registrants receive a confirmation email with the dial-in number, unique passcode, and registrant ID.

Will Kiniksa (KNSA) provide a replay of the Q3 2025 earnings call?

Yes. A replay will be posted on Kiniksa’s website approximately 48 hours after the event.

What topics will Kiniksa (KNSA) cover on the October 28, 2025 call?

Kiniksa will report its third quarter 2025 financial results and discuss recent portfolio execution.